Labetalol indications and usage: Difference between revisions

Jump to navigation Jump to search
ShiSheng (talk | contribs)
ShiSheng (talk | contribs)
No edit summary
Line 1: Line 1:
__NOTOC__
{{Labetalol}}
{{CMG}}; {{AE}} {{SS}}
__NOTOC__
__NOTOC__
{{Labetalol}}
{{Labetalol}}
Line 16: Line 11:




==References==
{{Reflist|2}}
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}


==References==
==References==

Revision as of 14:46, 5 February 2014

Labetalol
LABETALOL tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
LABETALOL injection® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Labetalol
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]


Indications And Usage

Labetalol HCl injection is indicated for control of blood pressure in severe hypertension. Labetalol hydrochloride tablets, USP may be used alone or in combination with other antihypertensive agents, especially thiazide and loop diuretics.[1][1]



References

  1. 1.0 1.1 "LABETALOL HYDROCHLORIDE TABLET, FILM COATED [WATSON LABORATORIES, INC.]". Retrieved 5 February 2014.

Template:WikiDoc Sources